X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (127) 127
Newspaper Article (53) 53
Patent (44) 44
Conference Proceeding (20) 20
Book Review (14) 14
Publication (14) 14
Book Chapter (3) 3
Dissertation (2) 2
Magazine Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (73) 73
index medicus (59) 59
female (56) 56
humans (55) 55
ovarian cancer (47) 47
beer (44) 44
biochemistry (44) 44
chemistry (44) 44
compositions or test papers therefor (44) 44
condition-responsive control in microbiological orenzymological processes (44) 44
enzymology (44) 44
measuring or testing processes involving enzymes, nucleicacids or microorganisms (44) 44
metallurgy (44) 44
microbiology (44) 44
mutation or genetic engineering (44) 44
processes of preparing such compositions (44) 44
spirits (44) 44
vinegar (44) 44
wine (44) 44
middle aged (31) 31
physics (30) 30
cancer (28) 28
ovarian neoplasms - pathology (28) 28
chemotherapy (26) 26
ovarian neoplasms - genetics (26) 26
adult (25) 25
ovarian neoplasms - drug therapy (25) 25
aged (24) 24
mutation (20) 20
survival (19) 19
testing (19) 19
carcinoma (18) 18
investigating or analysing materials by determining theirchemical or physical properties (18) 18
measuring (18) 18
breast-cancer (15) 15
hematology, oncology and palliative medicine (15) 15
patients (15) 15
poly polymerase (15) 15
prognosis (14) 14
aged, 80 and over (13) 13
care and treatment (13) 13
germ-line mutation (13) 13
information and communication technology [ict] specially adaptedfor specific application fields (13) 13
ovarian neoplasms - mortality (13) 13
platinum (13) 13
genes, brca1 (12) 12
genes, brca2 (12) 12
neoplasm staging (12) 12
breast cancer (11) 11
carcinoma, ovarian epithelial (11) 11
endocrine system diseases (11) 11
expression (11) 11
research (11) 11
survival analysis (11) 11
analysis (10) 10
antineoplastic agents - therapeutic use (10) 10
cancer therapies (10) 10
cisplatin (10) 10
open-label (10) 10
ovarian carcinoma (10) 10
phthalazines - adverse effects (10) 10
piperazines - adverse effects (10) 10
therapy (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (9) 9
brca1 protein - genetics (9) 9
disease-free survival (9) 9
health aspects (9) 9
neoplasm grading (9) 9
obstetrics & gynecology (9) 9
tumors (9) 9
abridged index medicus (8) 8
article (8) 8
bevacizumab (8) 8
medical research (8) 8
neoplasm recurrence, local - drug therapy (8) 8
ovarian neoplasms - metabolism (8) 8
phthalazines - therapeutic use (8) 8
piperazines - therapeutic use (8) 8
women (8) 8
animals (7) 7
antineoplastic agents (7) 7
antineoplastic agents - adverse effects (7) 7
brca1 (7) 7
brca1 protein (7) 7
brca2 mutations (7) 7
brca2 protein - genetics (7) 7
clinical trials (7) 7
genetic aspects (7) 7
gynecologic-oncology-group (7) 7
medicine, general & internal (7) 7
neoplasms, glandular and epithelial - pathology (7) 7
retrospective studies (7) 7
antimitotic agents (6) 6
brca2 protein (6) 6
children's books (6) 6
deoxyribonucleic acid--dna (6) 6
diseases (6) 6
double-blind method (6) 6
female genital diseases and pregnancy complications (6) 6
gene mutations (6) 6
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (229) 229
French (17) 17
German (7) 7
Chinese (3) 3
Korean (3) 3
Portuguese (2) 2
Spanish (2) 2
Japanese (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet Oncology, ISSN 1470-2045, 09/2018, Volume 19, Issue 9, pp. 1146 - 1147
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 11, pp. 1579 - 1589
Journal Article
Lancet, The, ISSN 0140-6736, 2014, Volume 384, Issue 9948, pp. 1099 - 1108
Journal Article
JOURNAL OF GYNECOLOGIC ONCOLOGY, ISSN 2005-0380, 09/2019, Volume 30, Issue 5, pp. e98 - e98
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2012, Volume 366, Issue 15, pp. 1382 - 1392
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 8, pp. 852 - 861
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2011, Volume 365, Issue 26, pp. 2484 - 2496
The addition of bevacizumab to chemotherapy (15 mg/kg for six cycles) followed by extended therapy with bevacizumab every 3 weeks for a total of 15 months of... 
CARBOPLATIN-PACLITAXEL | 1ST-LINE TREATMENT | MEDICINE, GENERAL & INTERNAL | INTERGROUP TRIAL | GYNECOLOGIC-ONCOLOGY-GROUP | SOLID TUMORS | ANGIOGENESIS | CYCLOPHOSPHAMIDE | EXPRESSION | INTRAPERITONEAL CISPLATIN | III TRIAL | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Carboplatin - administration & dosage | Combined Modality Therapy | Ovarian Neoplasms - mortality | Neoplasms, Glandular and Epithelial - surgery | Bevacizumab | Disease-Free Survival | Neoplasms, Glandular and Epithelial - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms, Glandular and Epithelial - drug therapy | Survival Analysis | Angiogenesis Inhibitors - therapeutic use | Carcinoma, Ovarian Epithelial | Quality of Life | Female | Paclitaxel - administration & dosage | Angiogenesis Inhibitors - adverse effects | Ovarian Neoplasms - drug therapy | Ovarian Neoplasms - surgery | Drugs | Dose-response relationship (Biochemistry) | Product/Service Evaluations | Drug therapy | Ovarian cancer | Risk groups | Body weight | Clinical trials | Survival | Angiogenesis | Chemotherapy | Womens health | Paclitaxel | Carboplatin | Vascular endothelial growth factor | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 15, pp. 1515 - 1524
Journal Article